Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.52 |
| ▸ | THRA | P10827 | 3/20 | 0.40 |
| ▸ | THRB | P10828 | 3/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.38 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | IAPP | P10997 | 2/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | LCK | P06239 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1404313 | 0.91 | FOLH1 (0.56) | FOLH1FFAR4BACE1FFAR1EGFR | |
| SCHEMBL18292001 | 0.89 | FOLH1 (0.54) | FOLH1THRATHRBFFAR4BACE1 | |
| SCHEMBL25741233 | 0.88 | FOLH1 (0.52) | FOLH1FFAR4BACE1POLBIAPP | |
| SCHEMBL27303602 | 0.88 | FOLH1 (0.52) | FOLH1THRATHRBFFAR4BACE1 | |
| SCHEMBL22571849 | 0.86 | FOLH1 (0.51) | FOLH1THRATHRBFFAR4BACE1 | |
| SCHEMBL18811749 | 0.86 | FOLH1 (0.58) | FOLH1THRATHRBFFAR1CA1 | |
| SCHEMBL22131080 | 0.85 | FOLH1 (0.52) | FOLH1BACE1IAPP | |
| SCHEMBL18811743 | 0.84 | FOLH1 (0.56) | FOLH1THRATHRBFFAR4CA1 | |
| SCHEMBL25797889 | 0.84 | FOLH1 (0.49) | FOLH1THRATHRBFFAR4BACE1 | |
| SCHEMBL29340370 | 0.84 | FOLH1 (0.51) | FOLH1FFAR4BACE1FFAR1EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024057277-A1 | DIAGNOSTIC PET IMAGING OF CARDIAC AMYLOIDOSIS | Beijing Lado Technology Co., Ltd. (CN) | 2024-03-21 | — | — | WO | disclosed |
| US-20230212549-A1 | COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212549-A1 | COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF | FIBP, FN1, TPX2 | FOLH1 1082/4885THRA 2231/4885THRB 3626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.